Innovative, patented crystallization technology has transformed conventional vitamin K2 menaquinone 7 into its purest form, retaining only its active ability to increase bone density and decrease arterial calcification as shown in unprecedented, targeted three-year research. Patented MenaQ7 Crystals is suitable for food, food supplements, premixes and multivitamins without the customary excipients resulting in space and weight savings in finished vitamin K2-containing products. With an available Drug Master File and self-affirmed GRAS, MenaQ7 Crystals conforms to many global food regulations.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.